Document is current
Any future updates will be listed below
-
Authors
Santin, Glaucia http://orcid.org/0000-0002-9925-3686
da Silva, Mariana Moreira Magnabosco
Villarreal, Vinicius Augusto
Laste, Leane Dhara Dalle
de Freitas Montin, Eduardo
Betiol, Luis Eduardo Ribeiro
Azevedo, Valderilio Feijó
-
Funding
Funding for this research was provided by:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001)
Edumed - Educação em Saude (NA)
- License Information
-
More Information
Article History
Received: 9 November 2019
Accepted: 30 April 2020
First Online: 27 May 2020
Ethics approval and consent to participate
: The study was conducted according to the ethical standards established in the Declaration of Helsinki of 1964 and its subsequent amendments and was approved by the Institution’s local ethics committee (Comitê de Ética em Pesquisa em Seres Humanos do CHC/UFPR # 66073817.0.0000.0096). All patients included in the study were fully informed about the research, and an ICF was obtained from all patients prior to their inclusion in the study.
: All authors are aware of the full content of the manuscript and provided consent for the submission to Advances in Rheumatology.
: Valderilio Azevedo:Latin American Forum on Biosimilars Coordinator; Principal Investigator in clinical trials sponsored by AbbVie Farmacêutica Ltda, Pfizer, Novartis Biociencias SA, Eli Lilly do Brasil Ltda., Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda., GlaxoSmithKline do Brasil, Genentech, Inc. UCB Biopharma AS.
